MBTPS2 mutations have been identified as the first X-linked cause of OI that is associated with a moderate to severe, potentially intrauterine lethal clinical phenotype (Lindert et al., 2016). The gene discussed is MBTPS2; the disease is osteogenesis imperfecta.